Quick Answer
MERIT MEDICAL SYSTEMS INC reported Total Revenue of $1.52 billion for fiscal year 2025.
MERIT MEDICAL SYSTEMS INC — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $1.52B +11.8% |
$1.36B +7.9% |
$1.26B +9.2% |
$1.15B +7.1% |
$1.07B +11.5% |
$963.88M -3.1% |
| Revenue (ASC 606) | $1.52B +11.8% |
$1.36B +7.9% |
$1.26B +9.2% |
$1.15B +7.1% |
$1.07B +11.5% |
$963.88M -3.1% |
| Net Income | $128.49M +6.8% |
$120.36M +27.5% |
$94.41M +26.7% |
$74.52M +53.8% |
$48.45M +592.3% |
-$9.84M -280.6% |
| Diluted EPS | $2.13 +4.9% |
$2.03 +25.3% |
$1.62 +25.6% |
$1.29 +53.6% |
$0.84 +566.7% |
-$0.18 -280.0% |
| Total Assets | $2.69B +11.1% |
$2.42B +4.0% |
$2.33B +39.7% |
$1.66B +1.0% |
$1.65B -1.0% |
$1.66B -5.3% |
| Cash and Equivalents | $446.40M +18.5% |
$376.71M -35.8% |
$587.04M +905.1% |
$58.41M -13.8% |
$67.75M +19.0% |
$56.92M +28.4% |
| Long-Term Debt | $734.04M +0.6% |
$729.55M -11.4% |
$823.01M +340.7% |
$186.76M -20.3% |
$234.40M -31.8% |
$343.72M -20.4% |
| Stockholders Equity | $1.58B +14.9% |
$1.38B +14.8% |
$1.20B +5.0% |
$1.14B +10.1% |
$1.04B +8.5% |
$958.58M +0.9% |
| R&D Expense | — | — | — | — | — | — |
| Operating Income | $184.72M +18.6% |
$155.69M +25.6% |
$123.94M +41.5% |
$87.56M +43.7% |
$60.92M +3999.9% |
-$1.56M -110.1% |
| Gross Profit | $738.27M +14.8% |
$643.33M +10.2% |
$583.87M +12.5% |
$519.10M +7.0% |
$485.33M +21.0% |
$401.18M -7.2% |
| Shares Outstanding | 59.42M +1.2% |
58.74M +1.5% |
57.86M +1.0% |
57.31M +1.3% |
56.57M +1.7% |
55.62M +0.7% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $384.16M | +13.0% | +0.4% |
| Revenue (ASC 606) | September 30, 2025 | $384.16M | +13.0% | +0.4% |
| Net Income | September 30, 2025 | $27.75M | -2.4% | -14.8% |
| Diluted EPS | September 30, 2025 | $0.46 | -4.2% | -14.8% |
| Total Assets | September 30, 2025 | $2.63B | +10.6% | +1.7% |
| Cash and Equivalents | September 30, 2025 | $392.46M | -25.0% | +14.8% |
| Long-Term Debt | September 30, 2025 | $732.92M | -2.3% | +0.2% |
| Stockholders Equity | September 30, 2025 | $1.53B | +15.6% | +2.8% |
| R&D Expense | June 30, 2019 | $16.33M | +6.6% | +1.8% |
| Operating Income | September 30, 2025 | $42.61M | +14.4% | -9.1% |
| Gross Profit | September 30, 2025 | $186.41M | +18.3% | +1.0% |
| Shares Outstanding | September 30, 2025 | 59.29M | +1.7% | +0.1% |
- MERIT MEDICAL SYSTEMS INC reported Total Revenue of $1.52 billion for fiscal year 2025.
- MERIT MEDICAL SYSTEMS INC showed an increase of +11.8% in Total Revenue compared to the prior fiscal year.
- MERIT MEDICAL SYSTEMS INC reported Revenue (ASC 606) of $1.52 billion for fiscal year 2025.
- MERIT MEDICAL SYSTEMS INC showed an increase of +11.8% in Revenue (ASC 606) compared to the prior fiscal year.
- MERIT MEDICAL SYSTEMS INC reported Net Income of $128.49 million for fiscal year 2025.
- MERIT MEDICAL SYSTEMS INC showed an increase of +6.8% in Net Income compared to the prior fiscal year.
- MERIT MEDICAL SYSTEMS INC reported Diluted EPS of $2.13 per share for fiscal year 2025.
- MERIT MEDICAL SYSTEMS INC showed an increase of +4.9% in Diluted EPS compared to the prior fiscal year.
- MERIT MEDICAL SYSTEMS INC reported Total Assets of $2.69 billion for fiscal year 2025.
- MERIT MEDICAL SYSTEMS INC showed an increase of +11.1% in Total Assets compared to the prior fiscal year.
- MERIT MEDICAL SYSTEMS INC reported Cash and Equivalents of $446.40 million for fiscal year 2025.
- MERIT MEDICAL SYSTEMS INC showed an increase of +18.5% in Cash and Equivalents compared to the prior fiscal year.
- MERIT MEDICAL SYSTEMS INC reported Long-Term Debt of $734.04 million for fiscal year 2025.
- MERIT MEDICAL SYSTEMS INC showed an increase of +0.6% in Long-Term Debt compared to the prior fiscal year.
- MERIT MEDICAL SYSTEMS INC reported Stockholders Equity of $1.58 billion for fiscal year 2025.
- MERIT MEDICAL SYSTEMS INC showed an increase of +14.9% in Stockholders Equity compared to the prior fiscal year.
- MERIT MEDICAL SYSTEMS INC reported R&D Expense of $59.53 million for fiscal year 2018.
- MERIT MEDICAL SYSTEMS INC showed an increase of +15.8% in R&D Expense compared to the prior fiscal year.
- MERIT MEDICAL SYSTEMS INC reported Operating Income of $184.72 million for fiscal year 2025.
- MERIT MEDICAL SYSTEMS INC showed an increase of +18.6% in Operating Income compared to the prior fiscal year.
- MERIT MEDICAL SYSTEMS INC reported Gross Profit of $738.27 million for fiscal year 2025.
- MERIT MEDICAL SYSTEMS INC showed an increase of +14.8% in Gross Profit compared to the prior fiscal year.
- MERIT MEDICAL SYSTEMS INC reported Shares Outstanding of 59.42 million shares for fiscal year 2025.
- MERIT MEDICAL SYSTEMS INC showed an increase of +1.2% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: